0001104659-16-095427.txt : 20160210 0001104659-16-095427.hdr.sgml : 20160210 20160210143402 ACCESSION NUMBER: 0001104659-16-095427 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20151231 FILED AS OF DATE: 20160210 DATE AS OF CHANGE: 20160210 EFFECTIVENESS DATE: 20160210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Versant Venture Management, LLC CENTRAL INDEX KEY: 0001560009 IRS NUMBER: 954767945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16849 FILM NUMBER: 161405012 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001560009 XXXXXXXX 12-31-2015 12-31-2015 false Versant Venture Management, LLC
One Sansome Street, Suite 3630 San Francisco CA 94104
13F HOLDINGS REPORT 028-16849 N
Robin L. Praeger Managing Director, Versant Venture Management, LLC 415-801-8100 /s/ Robin L. Praeger San Francisco CA 02-09-2016 0 7 170904743 false
INFORMATION TABLE 2 a16-3834_1informationtable.xml INFORMATION TABLE Clovis Oncology, Inc. Common Stock 189464100 14259560 407416 SH OTR 0 407416 0 Five Prime Therapeutics, Inc. Common Stock 33830X104 45324308 1092152 SH OTR 0 1092152 0 CymaBay Therapeutics, Inc. Common Stock 23257D103 1772135 1048601 SH OTR 0 1048601 0 Achaogen, Inc. Common Stock 004449104 7353812 1281152 SH OTR 0 1281152 0 Biotie Therapies Corp. ADS 09074D103 3855443 268672 SH OTR 0 268672 0 Ocular Therapeutix, Inc. Common Stock 67576A100 20758148 2215384 SH OTR 0 1281152 0 Glaukos Corporation Common Stock 377322102 77581337 32016637 SH OTR 0 268672 0